Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF285BP is based on a presumed or predicted pseudogene named "zinc finger protein 285B, pseudogene." Pseudogenes are DNA sequences resembling functional genes but are generally non-coding due to mutations, deletions, or lack of regulatory elements. The name suggests a relation to the zinc finger protein 285B family—members of which, if functional, typically serve as transcription factors characterized by the zinc finger DNA-binding motif[4][7]. However, no authoritative gene or protein database, such as NCBI Gene or GeneCards, currently lists "ZNF285BP" as an active protein or as a well-established pseudogene entry. No evidence exists that this entity encodes a functional product or serves as a therapeutic target. The term itself may be erroneous or a spurious bioinformatic annotation. Context and Interpretation: - The entry does not correspond to a functional receptor, enzyme, transporter, or transcription factor, and is not recognized as a drug target. - The name structure resembles zinc finger pseudogenes (e.g. other ZNF pseudogenes like ZNF271P[3], ZNF702P[6]), but those have specific entries. No such entry is found for "zinc finger protein 285B, pseudogene." - Zinc finger proteins as a family are known for their DNA/RNA/protein-binding capabilities and roles in gene regulation, but those properties do not apply to pseudogenes, which typically lack biological function[1][4][7]. If you need information about related, functional members of the zinc finger protein family or a different ZNF pseudogene, please clarify or specify the correct target.
None.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on zinc finger protein 285B, pseudogene (ZNF285BP).